학술논문
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆
Document Type
Article
Author
Wu, X.H.; Zhu, J.Q.; Yin, R.T.; Yang, J.X.; Liu, J.H.; Wang, J.; Wu, L.Y.; Liu, Z.L.; Gao, Y.N.; Wang, D.B.; Lou, G.; Yang, H.Y.; Zhou, Q.; Kong, B.H.; Huang, Y.; Chen, L.P.; Li, G.L.; An, R.F.; Wang, K.; Zhang, Y.; Yan, X.J.; Lu, X.; Lu, W.G.; Hao, M.; Wang, L.; Cui, H.; Chen, Q.H.; Abulizi, G.; Huang, X.H.; Tian, X.F.; Wen, H.; Zhang, C.; Hou, J.M.; Mirza, M.R.
Source
In Annals of Oncology April 2021 32(4):512-521
Subject
Language
ISSN
0923-7534